A detailed history of Perigon Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 8,561 shares of REGN stock, worth $6.12 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
8,561
Previous 8,319 2.91%
Holding current value
$6.12 Million
Previous $8.74 Million 2.93%
% of portfolio
0.25%
Previous 0.26%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$1024.09 - $1201.76 $247,829 - $290,825
242 Added 2.91%
8,561 $9 Million
Q2 2024

Aug 02, 2024

BUY
$883.2 - $1071.19 $211,084 - $256,014
239 Added 2.96%
8,319 $8.74 Million
Q1 2024

Apr 29, 2024

BUY
$902.69 - $993.35 $1.78 Million - $1.95 Million
1,968 Added 32.2%
8,080 $7.78 Million
Q4 2023

Jan 29, 2024

BUY
$775.18 - $881.7 $124,803 - $141,953
161 Added 2.71%
6,112 $5.37 Million
Q3 2023

Oct 30, 2023

BUY
$692.45 - $844.37 $387,772 - $472,847
560 Added 10.39%
5,951 $4.9 Million
Q2 2023

Aug 02, 2023

BUY
$700.03 - $830.35 $224,009 - $265,712
320 Added 6.31%
5,391 $3.87 Million
Q1 2023

May 03, 2023

BUY
$680.49 - $826.97 $163,317 - $198,472
240 Added 4.97%
5,071 $4.17 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $272,473 - $295,826
386 Added 8.68%
4,831 $3.49 Million
Q3 2022

Dec 13, 2022

BUY
$573.97 - $724.32 $691,633 - $872,805
1,205 Added 37.19%
4,445 $3.06 Million
Q2 2022

Aug 11, 2022

BUY
$548.35 - $738.84 $81,704 - $110,087
149 Added 4.82%
3,240 $1.92 Million
Q1 2022

May 16, 2022

SELL
$595.12 - $698.43 $255,901 - $300,324
-430 Reduced 12.21%
3,091 $2.16 Million
Q4 2021

Feb 11, 2022

BUY
$543.48 - $670.97 $7,065 - $8,722
13 Added 0.37%
3,521 $2.22 Million
Q3 2021

Nov 01, 2021

BUY
$574.03 - $680.96 $2.01 Million - $2.39 Million
3,508 New
3,508 $2.12 Million
Q3 2021

Oct 25, 2021

SELL
$574.03 - $680.96 $1.99 Million - $2.36 Million
-3,471 Closed
0 $0
Q2 2021

Jul 19, 2021

BUY
$472.8 - $558.54 $7,092 - $8,378
15 Added 0.43%
3,471 $1.94 Million
Q1 2021

May 17, 2021

BUY
$446.73 - $548.2 $947,961 - $1.16 Million
2,122 Added 159.07%
3,456 $1.64 Million
Q4 2020

Jan 28, 2021

SELL
$478.3 - $607.98 $41,133 - $52,286
-86 Reduced 6.06%
1,334 $644,000
Q3 2020

Nov 03, 2020

BUY
$544.75 - $658.21 $46,303 - $55,947
85 Added 6.37%
1,420 $795,000
Q2 2020

Jul 29, 2020

SELL
$493.32 - $643.92 $493 - $643
-1 Reduced 0.07%
1,335 $833,000
Q1 2020

Apr 17, 2020

BUY
$336.18 - $494.43 $195,320 - $287,263
581 Added 76.95%
1,336 $685,000
Q4 2019

Jan 13, 2020

SELL
$274.13 - $376.51 $548 - $753
-2 Reduced 0.26%
755 $281,000
Q2 2019

Aug 05, 2019

BUY
$299.6 - $414.82 $14,980 - $20,741
50 Added 7.07%
757 $237,000
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $17,487 - $20,659
47 Added 7.12%
707 $247,000
Q4 2018

Feb 11, 2019

SELL
$335.82 - $403.04 $17,462 - $20,958
-52 Reduced 7.3%
660 $276,000
Q3 2018

Nov 13, 2018

SELL
$351.14 - $408.51 $55,480 - $64,544
-158 Reduced 18.16%
712 $288,000
Q2 2018

Aug 09, 2018

BUY
$284.6 - $344.99 $247,602 - $300,141
870 New
870 $300,000
Q2 2018

Aug 07, 2018

SELL
$284.6 - $344.99 $17,645 - $21,389
-62 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$315.82 - $393.78 $19,580 - $24,414
62 New
62 $21,000
Q4 2017

Feb 14, 2018

SELL
$358.63 - $469.95 $166,404 - $218,056
-464 Closed
0 $0
Q3 2017

Dec 05, 2017

SELL
$431.38 - $504.0 $409,379 - $478,296
-949 Reduced 67.16%
464 $207,000
Q2 2017

Sep 12, 2017

BUY
N/A
1,413 New
1,413 $694,000
Q3 2011

Nov 14, 2022

BUY
N/A
1,205
4,445 $3.06 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.